Dasatinib worsens the effect of cetuximab in combination with fractionated radiotherapy in FaDu- and A431-derived xenografted tumours
Crossref DOI link: https://doi.org/10.1038/bjc.2014.432
Published Online: 2014-07-31
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Baro, M
de Llobet, L I
Figueras, A
Skvortsova, I
Mesia, R
Balart, J
License valid from 2014-07-31
Article History
Revised: 2 June 2014
Accepted: 9 July 2014
First Online: 31 July 2014